It is disturbing to regularly see the efforts of those for whom your disease respresents an opportunity. These are people who exploit the fact that people become ill, to make money. The medical devices industry is not all bad, many of its players are well-meaning, but plenty appear to be purely motivated by money.
The same cannot be said for the pharmaceutical industry, where the overwhelming intention is simply to make money and perhaps a secondary intention is to weild power. It has become impossible to say with any certainty that at some level there is some genuine interest in benefiting consumers.
But there are other hangers-on. These are people who seem excited when they discover yet another way to capitalise on misfortune. Consider the following press release for example.
Report on the global market for prostate cancer therapeutics
Reportlinker.com announces that a new market research report is available in its catalogue: Prostate Cancer Therapeutics – A Global Market Perspective http://www.reportlinker.com/p0164266/Prostate-Cancer-Therapeutics—A-Global-Market-Perspective.html
Growth in prostate cancer therapies can be attributed to the increase in number of prostate cancer incidences in men aged more than 60 years. Given the longevity of an average individual, and the rapidly aging world population, the risk of prostate cancer stands tall. Invasive cancer carries a high risk of spreading to the bone if left untreated, thereby making timely intervention of crucial importance. The market for world prostate cancer therapeutics continues to gain traction as companies explore advancements and improvements in drug delivery techniques translating to greater market opportunity.
Several options exist for treating prostate cancer in its early development stage. Radiation therapy or surgery offer effective cure when the disease is diagnosed in initial stages. External Beam Radiation Therapy entails release of radioactive beams, either exclusively to the prostate gland (radiation only for prostate) or may cover the adjacent pelvic lymph glands besides the prostate gland (full pelvic radiation). In Brachytherapy or crevice insertions, the surgeon keeps tiny seeds or pallets of radioactive substance straight inside the prostate gland.
These and other market data and trends are presented in “Prostate Cancer Therapeutics: A Global Market Perspective,” by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
SOURCE Reportlinker
The price of the report is $2,995. It is disturbing to think about who pays that kind of money for marketing information relating to those suffering from prostate cancer. But this is just one example.
The point is that while so many people stand to make money from disease, and it is a vast amount of money, we will always find a certain amount of motivation to keep people sick. So sales and marketing of processed and unhealthy foods, development and prescription of drugs, and false reassurance by having bureaucracies called Departments of Health, and similar, will continue.
Tags: disease exploitation, disease means money, therapy pedlars